Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.» Read More
DaVita could be a beneficiary among health care stocks from changes in the U.S. health care market, an analyst said Wednesday.
While Silicon Valley and other traditional high-tech hubs claim dominance as places for startups, demand for health care and other business services has put places like Indianapolis and Salt Lake City on the entrepreneurial map.
The managing partner of Google's venture capital, Bill Maris, says under-investment in health sciences is short-sighted.
The goal is to enable physicians and pharmaceutical companies to use complex genetic data to tailor treatment on an individual basis, according to Mike Pellini, CEO of Foundation Medical.
That may sound strange, but in a world where robots are becoming more common on assembly lines, in manufacturing plants and shipping centers, Baxter takes robotics to a new level.
Industries across the board are embracing the idea of collecting and analyzing data to predict future outcomes as a way to enhance product quality and gain a competitive edge.
Qualcomm's CEO Paul Jacobs says the smart phone will become a focal point for wirelessly connecting medical devices, diagnostics and sensors, and providing near real-time information.
The aging of America is taking a toll on the health care system. By 2050, the cost of treating Alzheimer's patients will hit $1 trillion a year.
Despite piles of research on the skin cancer risks of sun exposure and tanning beds, dermatologists and cancer groups struggle to persuade people to protect their skin from ultraviolet rays.
With 12 million Americans allergic to one food item or another, sales of specialty foods are soaring.
In what could be the ultimate in personalized medicine, animals bearing your disease, or part of your anatomy, can serve as your personal guinea pig, so to speak. Some researchers call them avatars, like the virtual characters in movies and online games the New York Times reports.
Despite gloomy data out of China weighing on the outlook for U.S. earnings, U.S. equities are looking attractive for U.S. investors, Sam Peters, CIO and portfolio manager at global investment management firm Leg Mason Capital Management, told CNBC on Thursday.
What the latest employment figures mean, experts say, is that getting the U.S. back to work remains—and is expected to be—a slow and painful process.
Alarm bells over the lack of high tech workers in the U.S. have been ringing for years. Most analysts say the problem is worse, but some say it's overblown.
Faced with more service members returning without limbs from Iraq and Afghanistan, scientists, the government and private-sector companies are using new materials, tools and techniques to create sophisticated prostheses for amputees.
If you're worried about how yours might fare during a downturn, consider a recession-proof industry, which caters to ongoing demands.
Looking ahead to 2050, Carl McDonald, Citi health care analyst, shares insight on how cost could change, which companies will benefit, and ways in which Medicare and Medicaid could develop.
The “Mad Money” host admits he made a mistake, and now recommends a different name in the health care information technology wars.
Medical device maker, Abiomed's CEO, Michael Minogue, discusses his company's earnings beat, and whether the ultra expensive stock, selling for 5.8 times next year's sales, still has room to run, with Mad Money's Jim Cramer.
Physicians are embracing Web-based software solutions that are bringing healthcare services into the home.